期刊文献+

冠状动脉介入治疗后造影剂肾病的危险因素研究 被引量:19

Risk factors of contrast-induced nephropathy after percutaneous coronary intervention
下载PDF
导出
摘要 目的研究冠状动脉粥样硬化性心脏病(冠心病)患者经皮冠状动脉介入(percutaneous coronaryintervention,PCI)治疗后发生造影剂肾病(contrast-induced nephropathy,CIN)的相关因素。方法选取广东省人民医院2008年11月至2009年12月患有冠心病并行PCI治疗的患者370例为研究对象。根据术后血清肌酐浓度变化情况分为两组,即造影剂肾病组(CIN组)58例,非造影剂肾病组(非CIN组)312例,回顾性调查分析两组患者的临床资料,分析发生造影剂肾病的相关因素。结果术后58例发生CIN,发生率为15.67%;相关分析发现年龄(r=0.193,P<0.001)、Ⅱ型糖尿病(r=0.104,P=0.045)、肾功能不全(r=0.331,P<0.001)、糖尿病肾病(r=0.150,P=0.004)、原发性高血压(高血压)(r=0.164,P=0.002)、贫血(r=0.127,P=0.015)、利尿药(r=0.300,P<0.001)的使用与CIN发生相关。Logistic回归分析发现,肾功能不全,高血压,手术前后使用利尿药为造影剂肾病的危险因素。结论肾功能不全,高血压和手术前后使用利尿药是PCI治疗后造影剂肾病的危险因素,在进行PCI治疗前应进做好预防措施。 Objectives To study the risk factors of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI) in patients with coronary artery disease. Methods Three hundred and seventy patients who performed PCI and had complete clinical data with medical records from November 2008 to December 2009 in Guangdong General Hospital were included in this study. The patients were divided into CIN group (n=58) and non- CIN group (n=312) according to the changes in serum creatinine after operation. We retrospectively analyzed the clinical information and adopted to logistic regression test to analyze the risk factors of CIN. Results There were 58 patients had CIN and CIN incidence rate was 15.67% in 370 patients after PCI. We found age (r=0.193, P〈0.001), diabetes (r=0.104,P=0.045), renal insufficiency (r=0.331, P〈0.001 ), diabetic nephropathy (r=0.150, P=0.004), hypertension (r=0.164, P=0.002), anemia (r=0.127, P=0.015) and diuretic (r=0.300, P〈0.001) correlated to occurrence of CIN. Logistic regression test showed that renal insufficiency, hypertension and use of diuretic after operation were risk factors of CIN. Conclusions Renal insufficiency, hypertension and use of diuretic during operation are risk factors of CIN after PCI in patients, thus relevant preventive care should be taken during PCI.
出处 《岭南心血管病杂志》 2012年第1期17-19,共3页 South China Journal of Cardiovascular Diseases
关键词 冠状动脉疾病 血管成形术 经腔 经皮冠状动脉 造影剂肾病 危险因素 水化 coronary artery disease pereutaneous coronary intervention contrast-induced nephropathy risk factors hydration treatment
  • 相关文献

参考文献12

  • 1BARTORELLI A L,MARENZI G.Contrast-induced nephro- pathy[J]. J Interv Cardiol, 2008, 21 (1): 74-85.
  • 2BRIGUORI C, AIROLDI F, MORICI N, et al. New pharmacological protocols to prevent or reduce contrast media nephropathy[J]. Minerva Cardioangiol, 2005, 53( 1): 49-58.
  • 3GRUBERG L, MEHRAN R, DANGAS G, et al. Acute renal failure requiring dialysis after percutaneous coronary interventions[J]. Catheter Cardiovasc Interv, 2001, 52(4): 409-416.
  • 4SOLOMON R J, MEHRAN R, NATARAJAN M K, et al Contrast-induced nephropathy and long-term adverse events: cause and effect? [J]. Clin J Am Soc Nephrol, 2009, 4(7) 1162-1169.
  • 5PUCELIKOVA T, DANGAS G, MEHRAN R. Contrast-induced nephropathy [J]. Catheter Cardiovasc Interv, 2008, 71 (1) : 62-72.
  • 6CHONG E, POH K K, LIANG S, et al. Risk factors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine[J]. Ann Acad Med Singapore, 2010, 39(5) : 374-380.
  • 7李勇,郭志刚,李鹏,侯玉清,屠燕.冠状动脉介入治疗诱发造影剂肾病的危险因素及预后[J].广东医学,2008,29(5):824-826. 被引量:9
  • 8张翩,倪兆慧,王玲,何奔,王肖龙,邱建平,郑昌柱,杨光敏,朱爱国.冠状动脉介入术患者造影剂肾病的危险因素多中心调查[J].中国中西医结合肾病杂志,2010,11(3):214-218. 被引量:24
  • 9BARTHOLOMEW B A, HARJAI K J, DUKKIPATI S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification[J]. Am J Cardiol, 2004, 93(12) : 1515-1519.
  • 10马兴杰,董岸莺,韩国华.造影剂肾病的研究进展[J].重庆医学,2011,40(13):1326-1329. 被引量:26

二级参考文献63

  • 1邹古明,颜红兵.造影剂肾病的诊断与治疗现状[J].中国介入心脏病学杂志,2005,13(3):194-196. 被引量:78
  • 2吉俊,丁小强,邹建洲,方艺.816例冠状动脉介入诊疗术患者造影剂肾病危险因素调查[J].中国临床医学,2005,12(5):851-853. 被引量:12
  • 3叶菡洋,袁伟杰,边琪,梅小斌,傅鹏,郭云珊,崔若兰.血管造影术后肾损害的临床相关危险因素探讨[J].中华肾脏病杂志,2006,22(6):375-376. 被引量:6
  • 4赵景宏,黄岚.造影剂肾病及预防措施的研究进展[J].重庆医学,2007,36(1):87-89. 被引量:15
  • 5[1]Murphy SW, Barrett BJ, Parfrey PS. Contrast nephropathy. J Am Soc Nephrol, 2000, 11:177
  • 6[2]Wang A, Holcslaw T, Bashore TM et al. Exacerbation of radio contrast rephrotoxicity by endothelin receptor antagonism. Kidney Int, 2000, 57:1675
  • 7[3]Rudnick MR, Berns JS, Cohen RM et al. Contrast mediaassociated nephrotoxiticy. Semin Nephrol, 1997, 17:15
  • 8Briguori C,Manganelli F,Scarpato P,et al.Acetylcysteine and contrast agent-associated nephrotoxicity[J].J Am Coll Cardiol,2002,40(2):298-303.
  • 9Neumayer HH,Junge W,Kufner A,et al.Prevention of radiocontrast-media-indrced nephrotoxicity by the calcium channel blocker nitrendipine:a prospective randomized clinical trial[J].Nephrol Dial Transplant,1989,4(12):1030-1036.
  • 10Ide JM,Lancelot E,Pines E,et al.Prophylaxis of iodinated contrastmedia-induced nephropathy:A pharmacological point of view[J].Invest Radiol,2004,39(3):155-170.

共引文献76

同被引文献207

引证文献19

二级引证文献119

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部